What Is Mark Skousen's "Swiss Army Bio-Knife" Company?

Wondering what Dr. Mark Skousen’s “Swiss Army Bio-Knife”presentation is about?

I had been receiving emails from his publisher for a while so I decided to see what it was all about.

I was particularly curious as to why Dr. Skousen was convinced this “Swiss Army Bio-Knife” biotech company is 2020’s biggest and best investment opportunity?

I researched it to find out more and put together this honest review.

Keep reading below to get all the info.

Before I start…

If you’re tired of scams and want a real solution for making money online check out my no.1 recommendation.

It’s helped me earn over $300,000 in the last 12 months alone:

Go here to see my no.1 recommendation for making money online

(This is a 100% free training)

Swiss Army Bio-Knife Review

Table of Contents

Introduction to Swiss Army Bio-Knife

The biotech company Mark is talking about is nestled in the high mountains of Switzerland.

It has been around for 24 years and it is about to take on a $40 billion (annual revenue) empire.

The “Swiss Army Bio-Knife” is a euphemism for a cure that this small company has developed.

Mark says that the Swiss Biotech company has developed a molecule that can cure a host of illnesses, including cancer, diabetes, Alzheimer’s, and most importantly, Rheumatoid Arthritis (RA)

In the process of developing its RA cure, it will take companies like Amgen and Johnson & Johnson out of the market and dominate the industry.

Its drug will be effective at curing Rheumatoid Arthritis without producing terrible side effects.

Mark then goes on a tangent saying that many things are happening that can easily sink the stock market. But by investing in the Swiss company, you will protect your financial position no matter the state of the economy.

I have reviewed other investment opportunities that are purported to be immune to the market like The Survival Blueprint and The Secret Permian

Who is behind the “Swiss Army Bio-Knife” presentation?

Mark Skousen Ph.D. is an economist, investor, author, and university professor.

He has written more than 25 books and was recognized as one of the most influential economists alive in 2018.

I have reviewed his other presentations and products, including Five Star Trader, TNT Trade Alert, The Winners Circle, and Home Run Trader

Grantham University named its business school after him to recognize his contributions to economics and finance.

Now it goes by the name “The Mark Skousen School of Business.”

He is a regular guest on Larry Kudlow & Company, which airs on CNBC.

He has even been hired by many big companies to offer his economic advice.

How does Investing in the “Swiss Army Bio-Knife” Work?

Since the Swiss company’s cure will be more effective than what we have on the market for Rheumatoid Arthritis, it will grab hold of the market and become the leader.

With revenues expected to hit up to $40 billion, Mark thinks that the stock will follow suit.

The caveat is that the company is privately owned.

However, you can invest in the American biotech company that acquired it.

Mark calls the public American company, American X – it is not the real name, just a placeholder.

American X is funding the Swiss company’s research and using the tech it has developed to fashion cures for the other diseases.

American X already has over 40 FDA-approved products with others in development.

If you add the Swiss cure to its roster and its impact on the the conservative sales revenue estimates, its future looks bright.

Furthermore, its shares have almost tripled in the past 10 years and it pays a dividend of about 4%.

Research Reports

Dr. Mark Skousen has prepared a few reports with various investment opportunities. They are as follows:

American X Unmasked: The biotech behemoth with $52 billion in annual sales. This report reveals the names of the biotech company behind the Swiss Army Bio-Knife as well as the real name of American X.
The Age of Artificial Intelligence and the Multi-Millionaires it Will Create. This report details an AI company that will produce vital software and hardware for that sector.
Skousen’s 5 Favorite High-Income Growth Stocks. This report reveals the investments that Skousen would recommend that you add to your portfolio if you are looking for dividend stocks. They come from real estate, oil, software development, and mining.
The Next Healthcare Powerhouse: A 12-bagger in the Making. This company specializes in combating neurodegenerative diseases.
Get a Year’s Worth of Profits in Just 5 Minutes! It contains five stocks that have consistently beaten the DJIA and S&P 500 indexes for 18 years. They also pay dividends.
Live Long & Prosper with Dr. Skousen’s #1 Biotech Pick. This company developed a technology that does heart imaging to allow your doctor to examine your heart.

To get them, you have to subscribe to Dr. Skousen’s newsletter, Forecasts and Strategies.

As a subscriber, you will access his latest buy recommendations from various sectors of the economy and his predictions regarding the economy.

Subscription Fee

The annual subscription fee is $49.95

Performance Guarantee

The publisher also offers Forecasts and Strategies with a 30-day, money-back guarantee.

Is Swiss Army Bio-Knife Legit?

I think that “Swiss Army Bio-Knife” is legit because Dr. Skousen is the one recommending it.

If you are looking for an authoritative voice in the world of economics, you can’t look past Dr. Mark Skousen.

His achievements alone in that field can fill a book, but that’s not the only reason why I find his advice compelling.

I value his track record with his previous recommendations more than his accomplishments in the field of economics when it comes to investments. He has revealed many “diamonds” in his illustrious career and it’s no surprise that he has garnered a cadre of loyal readers who follow his recommendations to the letter.

Swiss Army Bio-Knife Verdict

Dr. Skousen has correctly called many stock market moves in the past three decades.

People who ignored his advice lost money, according to his publisher.

Of course, he has collected a couple of wrong calls but he wouldn’t publicize that in a pitch.

Now, in 2020 he thinks that the best investment will be biotech stocks.

These stocks have had it rough in the past one year but he expects that to change moving forward.

The company behind the “Swiss Army Bio-Knife” will be leading the charge with its “crash-resistant” stock.

Before you take the leap of faith and invest in it, you should block out the hyperboles and analyze it objectively.

Does it fit into your portfolio? Does it suit your overall investment strategy?

Before you leave

If you’re tired of scams and want a real solution for making money online check out my no.1 recommendation.

It’s helped me earn over $300,000 in the last 12 months alone:

Go here to see my no.1 recommendation for making money online

(This is a 100% free training)

Mark Charles

Mark Charles is the founder of NoBSIMReviews and has been making a 6-figure income online for over 10 years.

After reviewing 1000’s of programs, he knows what works and what doesn’t:

Go here to see the best business to start in 2024!